Filter the drugs by their status, phase of research and how they help

COVID-19 is respiratory dissease caused by SARS-CoV-2 virus. Browse the database of drugs treating specific mutations compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Conivaptan HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Digitoxin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/01/2020 Aug/12/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jul/31/2020 Aug/12/2020 0
Clofazimine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/24/2020 Jul/28/2020 0
Remdesivir Emergency use authorization Experimental Antiviral Jul/24/2020 Aug/03/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Jul/22/2020 Aug/12/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Jul/22/2020 Aug/12/2020 0
Tilorone 2HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/06/2020 Jul/09/2020 0
Amlodipine Besylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/06/2020 Jul/09/2020 0
Raloxifene HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/06/2020 Jul/09/2020 0